File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Pilot study on the use of sublingual misoprostol in termination of pregnancy up to 7 weeks gestation

TitlePilot study on the use of sublingual misoprostol in termination of pregnancy up to 7 weeks gestation
Authors
KeywordsMedical abortion
Misoprostol
Sublingual
Issue Date2003
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/contraception
Citation
Contraception, 2003, v. 68 n. 2, p. 97-99 How to Cite?
AbstractBackground: This study was conducted to assess the efficacy and incidence of side effects of a regimen of repeated doses of 400 μg sublingual misoprostol for termination of pregnancy of <7 weeks gestation. Method: Fifty women were given 400 μg sublingual misoprostol every 3 h for three doses. Two additional doses were given if necessary. Results: Forty-three women (86%) had a complete abortion. Two women (4%) had incomplete abortion and 5 (10%) had an ongoing pregnancy. The median interval between the first dose of misoprostol and the passage of tissue mass was 14.1 h (3.25-561.6 h). The median duration of vaginal bleeding was 20 days (8-85 days). Side effects were mild and there was no significant drop in hemoglobin level. Conclusions: Our preliminary results on sublingual misoprostol show that it is a promising method for medical termination of pregnancy of <7 weeks. It may be used as an alternative for women who do not want surgical evacuation and who live in an area where mifepristone is not available. © 2003 Elsevier. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/87280
ISSN
2015 Impact Factor: 2.788
2015 SCImago Journal Rankings: 1.557
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorCheung, Wen_HK
dc.contributor.authorTang, OSen_HK
dc.contributor.authorLee, SWHen_HK
dc.contributor.authorHo, PCen_HK
dc.date.accessioned2010-09-06T09:27:39Z-
dc.date.available2010-09-06T09:27:39Z-
dc.date.issued2003en_HK
dc.identifier.citationContraception, 2003, v. 68 n. 2, p. 97-99en_HK
dc.identifier.issn0010-7824en_HK
dc.identifier.urihttp://hdl.handle.net/10722/87280-
dc.description.abstractBackground: This study was conducted to assess the efficacy and incidence of side effects of a regimen of repeated doses of 400 μg sublingual misoprostol for termination of pregnancy of <7 weeks gestation. Method: Fifty women were given 400 μg sublingual misoprostol every 3 h for three doses. Two additional doses were given if necessary. Results: Forty-three women (86%) had a complete abortion. Two women (4%) had incomplete abortion and 5 (10%) had an ongoing pregnancy. The median interval between the first dose of misoprostol and the passage of tissue mass was 14.1 h (3.25-561.6 h). The median duration of vaginal bleeding was 20 days (8-85 days). Side effects were mild and there was no significant drop in hemoglobin level. Conclusions: Our preliminary results on sublingual misoprostol show that it is a promising method for medical termination of pregnancy of <7 weeks. It may be used as an alternative for women who do not want surgical evacuation and who live in an area where mifepristone is not available. © 2003 Elsevier. All rights reserved.en_HK
dc.languageengen_HK
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/contraceptionen_HK
dc.relation.ispartofContraceptionen_HK
dc.rightsContraception. Copyright © Elsevier Inc.en_HK
dc.subjectMedical abortionen_HK
dc.subjectMisoprostolen_HK
dc.subjectSublingualen_HK
dc.titlePilot study on the use of sublingual misoprostol in termination of pregnancy up to 7 weeks gestationen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=0010-7824&volume=68&issue=2&spage=97&epage=99&date=2003&atitle=Pilot+study+on+the+use+of+sublingual+misoprostol+in+termination+of+pregnancy+up+to+7+weeks+gestation+en_HK
dc.identifier.emailHo, PC:pcho@hku.hken_HK
dc.identifier.authorityHo, PC=rp00325en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/S0010-7824(03)00134-3en_HK
dc.identifier.pmid12954520-
dc.identifier.scopuseid_2-s2.0-0041327961en_HK
dc.identifier.hkuros92165en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-0041327961&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume68en_HK
dc.identifier.issue2en_HK
dc.identifier.spage97en_HK
dc.identifier.epage99en_HK
dc.identifier.isiWOS:000185194000004-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridCheung, W=7202743060en_HK
dc.identifier.scopusauthoridTang, OS=7006723402en_HK
dc.identifier.scopusauthoridLee, SWH=23990967700en_HK
dc.identifier.scopusauthoridHo, PC=7402211440en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats